A significant milestone in the history of FAVEA was the launch of its own patented COMBICAPS® technology, which enabled the combination of several active ingredients into one capsule. This innovative approach not only became a symbol of the company's originality and technical sophistication, but also paved the way for expansion into foreign markets.

FAVEA continued its tradition of innovation in 2022, when it launched the unique “capsule-in-capsule” technology. This modern pharmaceutical form represents a further step in the possibilities of combining and gradually releasing active ingredients, thereby strengthening the company's uniqueness and competitive advantage in the global market.

Over the years, FAVEA has transformed from a regional manufacturer into a respected partner operating in the European and global markets. Thanks to the systematic building of know-how, investments in development and long-term partnerships, a small Czech company has become a company with a global reach and trend.

Today, FAVEA follows its roots and at the same time continues the tradition of innovation - remaining true to its mission to contribute to the development of modern solutions that support prevention, health and quality of life.